supplementNot FDA-approvedPrescription only (US)Piracetam is approved as a prescription medicine (e.g., for myoclonus) in several EU countries and elsewhere, but it is not FDA-approved and cannot be legally marketed as a dietary supplement in the US
PiracetamBenefits, Dosage & Interactions
Also known as: Nootropil
Piracetam is a compound that gained attention in the mid-20th century, often described as a nootropic. It is a derivative of GABA (gamma-aminobutyric acid), although its mechanism of action does not primarily involve GABA receptors. Research on Piracetam focuses on cognition and mood.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 1 human randomized trial and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1 human randomized trial and regulatory approval on file.
Plasma half-life
Not applicable
Typical timing
morning
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- Trials pooled in the aphasia meta-analysis and the coronary bypass RCT used doses in the range of 2.4–4.8 g/day, typically divided into two or three doses[1][2][3][4]
- Route studied
- Oral (tablets or solution); some post-stroke trials used intravenous loading[1][2][3][4]
Reported for Piracetam in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Piracetam entry is written from. Each number matches an inline marker above.
- [1]Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled TrialsZhang J, Wei R, Chen Z, Luo B · CNS Drugs · 2016 · Peer-reviewed · PMID 27236454
- [2]Cognitive effects of piracetam in adults with memory impairment: A systematic review and meta-analysisGouhie FA, Barbosa KO, Cruz ABR, Wellichan MM, Zampolli TM · Clinical Neurology and Neurosurgery · 2024 · Peer-reviewed · PMID 38878641
- [3]Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placeboSzalma I, Kiss A, Kardos L, Horváth G · The Annals of Thoracic Surgery · 2006 · Peer-reviewed · PMID 16996947
- [4]Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disordersMalykh AG, Sadaie MR · Drugs · 2010 · Peer-reviewed · PMID 20166767
How to track Piracetam doses
Tracking Piracetam well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Piracetam with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is morning. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Piracetam through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Piracetam alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg
- Time of day
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Piracetam dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Piracetam studied for?
What is Piracetam?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Piracetam is a compound that gained attention in the mid-20th century, often described as a nootropic. It is a derivative of GABA (gamma-aminobutyric acid), although its mechanism of action does not primarily involve GABA receptors. First synthesized in the 1960s, it has been studied for its potential effects on cognitive functions, particularly in areas like memory and learning. It is available under various brand names, with Nootropil being one of the most recognized globally. While extensively studied, its classification and regulatory status vary significantly across different countries, being available as a prescription drug in some, and an over-the-counter supplement in others, or not approved for medical use in others (Examine.com, DrugBank).
Structurally, Piracetam is a cyclic derivative of GABA, with the chemical formula C6H10N2O2. Its half-life in the body is approximately 5 hours, meaning it takes about 5 hours for half of the administered dose to be eliminated. It is generally lipophilic, allowing it to cross the blood-brain barrier. Piracetam's primary route of excretion is via the kidneys, largely unchanged (DrugBank). It can be taken with or without food, and has been studied for morning administration. It is not an injectable compound.
What does the research say about Piracetam?
Tap a section to expand.
Piracetam's precise mechanism of action is still not fully understood, but research suggests several pathways through which it may exert its effects. It is thought to influence neuronal membrane fluidity, which can enhance cell-to-cell communication and improve cellular resistance to hypoxia (lack of oxygen). This modification of the phospholipid bilayer in cell membranes may lead to increased receptor density and improved neurotransmission (DrugBank).
One proposed mechanism involves an enhancement of cholinergic system activity. Piracetam may modulate acetylcholine release and density of cholinergic receptors, particularly muscarinic acetylcholine receptors. This could lead to improved learning and memory processes, given acetylcholine's crucial role in these functions (Examine.com).
Additionally, Piracetam has been shown to influence AMPA receptor function, which are a type of ionotropic glutamate receptor. By modulating AMPA receptor activity, it may enhance synaptic plasticity, a key process underlying learning and memory formation. It does not appear to directly bind to AMPA receptors but rather influences their functional state (DrugBank).
Another aspect of Piracetam's mechanism involves its potential to improve mitochondrial function and ATP production, particularly under conditions of stress or hypoxia. This could contribute to enhanced brain energy metabolism and overall neuronal resilience. It may also modulate neurotransmitter systems beyond acetylcholine and glutamate, though these are less consistently highlighted in the literature (PubChem). The overall effect is thought to optimize existing cognitive processes rather than inducing new ones.
Source for this section: Sources for How does Piracetam work?: Jumps to this entry in the sources and references list at the end of the page.
Piracetam has been studied for a range of cognitive applications, particularly those related to memory, learning, and cerebral circulation. These are some of the areas where potential benefits have been investigated:
* **Cognitive Enhancement in Age-Related Decline:** Studies have explored Piracetam's use in individuals experiencing age-associated cognitive impairment, including conditions like Alzheimer's disease and vascular dementia. Some research suggests it might help improve cognitive scores, particularly in memory and attention domains over extended periods, although results have been mixed across trials (Cochrane, NIH ODS Clinical Trials).
* **Post-Stroke Cognitive Recovery:** Piracetam has been investigated for its potential role in neurological recovery following ischemic stroke, particularly in improving verbal fluency and other cognitive functions. Research indicates that it might contribute to neuroplasticity and recovery of brain function after such events, possibly by improving microcirculation and neuronal metabolism (DrugBank).
* **Myoclonus Treatment:** Piracetam is recognized in some regions as an adjunctive treatment for cortical myoclonus, a neurological disorder characterized by sudden, involuntary muscle jerks. It is believed to act by stabilizing neuronal activity and reducing hyperexcitability in the motor cortex (DrugBank).
* **Dyslexia and Learning Difficulties:** Earlier research examined Piracetam's potential to improve reading ability and other cognitive functions in children with dyslexia. Some studies suggested modest improvements in verbal learning and reading speed, but this application is less widely recognized or endorsed currently (Examine.com).
* **General Cognitive Function:** In healthy individuals without diagnosed cognitive impairment, the evidence for significant cognitive enhancement from Piracetam is less robust and more controversial. While some anecdotal reports and small studies suggest benefits in areas like memory and concentration, large-scale, high-quality trials are minimal, and results often show subtle rather than dramatic effects (Examine.com).
It is important to note that while these areas have been studied, the extent and clinical significance of piracetam's benefits can vary, and regulatory bodies in different countries have reached different conclusions regarding its approved uses.
The evidence supporting the benefits of Piracetam varies depending on the medical condition and population studied. For conditions like cortical myoclonus, there is clearer evidence of efficacy, leading to its approval for this use in several countries (DrugBank).
In the context of cognitive decline, particularly in conditions like Alzheimer's or vascular dementia, a Cochrane review found some evidence suggesting modest cognitive improvements, particularly regarding memory and global clinical impression. However, the reviewers often highlight the need for larger, well-designed trials due to methodological limitations in existing studies. For instance, some positive findings relate to very long-term use, and separating the effects of Piracetam from other interventions can be challenging (Cochrane Library).
For post-stroke cognitive impairment, studies (often cited by DrugBank or PubChem) have indicated Piracetam's potential to improve functional recovery and cognitive outcomes, particularly when administered shortly after the event. These studies often focus on specific cognitive domains like language and motor function.
Regarding cognitive enhancement in healthy individuals, the scientific community holds a more cautious stance. While some individuals report subjective benefits, robust, double-blind, placebo-controlled trials demonstrating significant and consistent improvements in cognitive functions like memory, focus, or processing speed in healthy adults are largely lacking or have yielded inconclusive results. Examine.com notes that while mechanisms exist that could theoretically lead to enhancement, practical demonstration in healthy populations is weak.
The regulatory landscape reflects this mixed evidence. While approved in many European countries for certain neurological conditions, the U.S. FDA, for example, has not approved Piracetam as a drug, classifying it in a different regulatory category (FDA guidelines). This highlights the ongoing debate and varying interpretations of the available clinical evidence.
Piracetam is generally considered to have a favorable safety profile compared to many other psychoactive compounds. However, like all substances, it can cause side effects. Common side effects reported across studies and clinical use include:
* Nervousness
* Insomnia
* Agitation or anxiety
* Depression
* Drowsiness or fatigue
* Headache
* Gastrointestinal disturbances (e.g., nausea, diarrhea, abdominal pain)
* Weight gain
Less commonly, more severe reactions such as allergic reactions, confusion, hallucinations, or an increase in epileptic seizures (especially in susceptible individuals) have been reported, although these are rare (Mayo Clinic, DrugBank). Withdrawal symptoms, such as rebound anxiety or agitation, have also been reported upon abrupt cessation, particularly after long-term high-dose use. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Individuals should exercise caution and consult a healthcare provider before using Piracetam, especially if they have pre-existing medical conditions:
* **Renal Impairment:** Piracetam is primarily excreted by the kidneys. Individuals with impaired kidney function (renal insufficiency) may require dose adjustments or should avoid its use altogether, as accumulation could lead to increased side effects (DrugBank).
* **Hemorrhagic Disorders:** Due to its potential to affect platelet aggregation, Piracetam should be used with caution in individuals with known bleeding disorders or those undergoing major surgery (EMA SmPC).
* **Epilepsy:** While sometimes used to reduce myoclonus seizures, Piracetam can, paradoxically, lower the seizure threshold in some epileptic individuals or exacerbate seizure activity upon abrupt discontinuation (PubChem).
* **Pregnancy and Breastfeeding:** There is insufficient data to establish the safety of Piracetam during pregnancy and breastfeeding. Therefore, its use is generally not recommended in these populations unless clearly indicated and carefully monitored by a physician (EMA SmPC).
* **Abrupt Withdrawal:** Discontinuation of Piracetam, especially after long-term use, should be gradual to avoid potential withdrawal symptoms like rebound confusion, agitation, or myoclonic seizures (DrugBank).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Piracetam is specifically contraindicated in certain situations to prevent adverse outcomes. These contraindications include:
* **Severe Renal Impairment:** Patients with severe kidney disease, particularly those with a creatinine clearance below a specific threshold (e.g., <20 mL/min), should not use Piracetam due to the risk of accumulation and toxicity (DrugBank, EMA SmPC).
* **Cerebral Hemorrhage:** Due to its potential to interfere with platelet function, Piracetam is contraindicated in individuals experiencing acute cerebral hemorrhage (brain bleeding) or with a history of recurrent hemorrhagic strokes (Mayo Clinic, DrugBank).
* **Huntington's Disease:** While once explored for certain neurological conditions, Piracetam is contraindicated in patients with Huntington's chorea due to reports of symptom exacerbation (DrugBank).
* **Known Hypersensitivity:** Individuals with a known allergy or hypersensitivity to Piracetam or any of its excipients should not use the compound (PubChem).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
When considering Piracetam, it is important to be aware of potential interactions with other medications and substances:
* **Anticoagulants and Antiplatelet Agents:** Piracetam may have a mild anti-aggregatory effect on platelets. Therefore, concurrent use with anticoagulants (e.g., warfarin, heparin) and antiplatelet drugs (e.g., aspirin, clopidogrel) could theoretically increase the risk of bleeding. Close monitoring of coagulation parameters is advisable (DrugBank).
* **Thyroid Hormones:** There have been isolated reports of confusion, irritability, and sleep disturbance when Piracetam was combined with thyroid hormone extracts, particularly a T3/T4 combination. Caution is advised, and monitoring for these symptoms is recommended (PubChem).
* **CNS Depressants:** Although Piracetam is not a direct CNS depressant, there is theoretical concern for additive effects when combined with other CNS depressants, particularly if they affect neurotransmitter systems that Piracetam also modulates. However, robust data on this interaction is generally limited.
* **Other Nootropics:** Combining Piracetam with other nootropic compounds can be complex. While often done in personal experimentation, scientific data on the safety and efficacy of such combinations is largely absent or based on anecdotal reports, making it difficult to predict interactions or additive effects (Examine.com).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Piracetam is often recommended for morning administration, or divided into multiple doses throughout the day due to its approximate 5-hour half-life. For sustained levels in the body, clinicians may advise taking it two or three times daily. It can be taken with or without food, as food does not significantly alter its absorption. However, taking it with food might help mitigate any potential gastrointestinal discomfort for sensitive individuals (DrugBank). The specific frequency and timing of Piracetam administration should always be user-directed and set by a licensed clinician, especially for therapeutic uses.
Source for this section: Sources for When should you take Piracetam?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Piracetam?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any glp1 + supplement | Note | Category ruleConfidence: theoretical | GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.Source pending | Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider. |
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Alpha-GPC | Complementary | Compound pairConfidence: theoretical | Racetams increase acetylcholine turnover; adding a choline source can prevent headaches from choline depletion.Source pending | Consider stacking 300–600 mg alpha-GPC with racetam doses. |
Frequently asked questions about Piracetam
No, Piracetam is not classified as a stimulant. Unlike compounds such as caffeine or amphetamines, it does not directly stimulate the central nervous system. Its mechanism of action is thought to modulate existing brain functions rather than acutely increasing neural activity (Examine.com).
The onset of Piracetam's effects can vary significantly. For some, subtle cognitive changes might be noticeable within days to weeks, while others may require several weeks or months of consistent use to observe more pronounced effects, especially in conditions involving chronic cognitive impairment. The full therapeutic benefit might only be apparent after longer-term administration (DrugBank).
Piracetam is generally not considered an addictive substance. It does not typically produce the euphoric effects or strong cravings associated with addictive drugs. However, abrupt cessation after long-term, high-dose use can sometimes lead to rebound agitation, anxiety, or other withdrawal-like symptoms, particularly in specific patient populations like those with myoclonus (DrugBank, PubChem).
Long-term safety data for Piracetam is more established in the contexts where it has been medically approved, such as for certain neurological conditions. In these cases, it often demonstrates a relatively favorable safety profile. However, continued medical supervision is recommended for any long-term use, particularly given its renal excretion and potential for infrequent side effects (EMA SmPC).
No, the legal and regulatory status of Piracetam varies widely by country. In many European countries, it is available as a prescription drug. In other regions, it may be sold as an over-the-counter supplement, or it may not be approved for medical use at all (e.g., in the United States, it is not approved by the FDA as a drug). It's crucial to check local regulations.
As a supplement, Piracetam can overlap with other supplements, prescription medicines, hormones and peptides. Because Piracetam is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Piracetam with no sign-up.
Piracetam is typically taken in the morning. Amounts for this supplement vary by protocol, formulation and individual response, so follow the dose your clinician or the product label specifies.
Whether Piracetam fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to Piracetam. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Piracetam varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Piracetam depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Piracetam the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 4843(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/4843
Verify at
Publisher search links for Piracetam. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Piracetam?
Plain-text summary, safe to quote verbatim:
Piracetam is a compound that gained attention in the mid-20th century, often described as a nootropic. It is a derivative of GABA (gamma-aminobutyric acid), although its mechanism of action does not primarily involve GABA receptors. Research on Piracetam focuses on cognition and mood.
Source: DoseRoutine — https://doseroutine.com/library/piracetam
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Piracetam — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/piracetam
What compounds are similar to Piracetam?
Others in the supplement category or studied for the same goals.
Which goals is Piracetam used for?
Other compounds studied for the same benefits as Piracetam.
Continue exploring
See every compound DoseRoutine catalogs for these goals.